# SVT-15652 Otic Solution for the Treatment of Otomycosis

> **NCT03686384** · PHASE3 · COMPLETED · sponsor: **Salvat** · enrollment: 217 (actual)

## Conditions studied

- Otomycosis

## Interventions

- **DRUG:** SVT-15652
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03686384
- **Lead sponsor:** Salvat
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-27
- **Primary completion:** 2021-10-25
- **Final completion:** 2021-10-25
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03686384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03686384, "SVT-15652 Otic Solution for the Treatment of Otomycosis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03686384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*